These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37296266)

  • 21. Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin.
    Sierra-Ramirez A; López-Aceituno JL; Costa-Machado LF; Plaza A; Barradas M; Fernandez-Marcos PJ
    Aging (Albany NY); 2020 Jun; 12(12):11337-11348. PubMed ID: 32584785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile.
    Krzystyniak A; Wesierska M; Petrazzo G; Gadecka A; Dudkowska M; Bielak-Zmijewska A; Mosieniak G; Figiel I; Wlodarczyk J; Sikora E
    Aging (Albany NY); 2022 Jan; 14(2):572-595. PubMed ID: 35042834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics.
    Gao Y; Wu T; Tang X; Wen J; Zhang Y; Zhang J; Wang S
    Geroscience; 2023 Jun; 45(3):1775-1790. PubMed ID: 36648735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions.
    Lee E; Carreras-Gallo N; Lopez L; Turner L; Lin A; Mendez TL; Went H; Tomusiak A; Verdin E; Corley M; Ndhlovu L; Smith R; Dwaraka VB
    Aging (Albany NY); 2024 Feb; 16(4):3088-3106. PubMed ID: 38393697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of gingerenone A as a novel senolytic compound.
    Moaddel R; Rossi M; Rodriguez S; Munk R; Khadeer M; Abdelmohsen K; Gorospe M; Ferrucci L
    PLoS One; 2022; 17(3):e0266135. PubMed ID: 35349590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice.
    Novais EJ; Tran VA; Johnston SN; Darris KR; Roupas AJ; Sessions GA; Shapiro IM; Diekman BO; Risbud MV
    Nat Commun; 2021 Sep; 12(1):5213. PubMed ID: 34480023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design.
    Ruggiero AD; Vemuri R; Blawas M; Long M; DeStephanis D; Williams AG; Chen H; Justice JN; Macauley SL; Day SM; Kavanagh K
    Geroscience; 2023 Oct; 45(5):2785-2803. PubMed ID: 37261678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined use of dasatinib and quercetin alleviates overtraining-induced deficits in learning and memory through eliminating senescent cells and reducing apoptotic cells in rat hippocampus.
    Wang C; Kang Y; Liu P; Liu W; Chen W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Behav Brain Res; 2023 Feb; 440():114260. PubMed ID: 36535433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
    Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
    EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Senolytics cocktail dasatinib and quercetin alleviate chondrocyte senescence and facet joint osteoarthritis in mice.
    Zhao J; Zheng L; Dai G; Sun Y; He R; Liu Z; Jin Y; Wu T; Hu J; Cao Y; Duan C
    Spine J; 2024 Sep; ():. PubMed ID: 39343238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dasatinib and quercetin increase testosterone and sperm concentration in mice.
    Garcia DN; Hense JD; Zanini BM; Isola JVV; Pradiee J; Prosczek JB; Alvarado-Rincón JA; Mondadori RG; Mason JB; Brieño-Enríquez MA; Barros CC; Stout MB; Masternak MM; Schneider A
    Physiol Int; 2023 Jun; 110(2):121-134. PubMed ID: 37235453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice.
    Pastor-Fernández A; Bertos AR; Sierra-Ramírez A; Del Moral-Salmoral J; Merino J; de Ávila AI; Olagüe C; Villares R; González-Aseguinolaza G; Rodríguez MÁ; Fresno M; Gironés N; Bustos M; Smerdou C; Fernandez-Marcos PJ; von Kobbe C
    Aging Cell; 2023 Mar; 22(3):e13771. PubMed ID: 36704839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MASLD does not affect fertility and senolytics fail to prevent MASLD progression in male mice.
    Hense JD; Garcia DN; Zanini BM; Barreto MM; Perreira GC; Isola JVV; de Brito C; Fornalik M; Mondal SA; Ávila BM; Oliveira TL; Rice HC; Lacy CI; Vaucher RA; Mason JB; Masternak MM; Stout MB; Schneider A
    Sci Rep; 2024 Jul; 14(1):17332. PubMed ID: 39068167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs.
    Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting senescent cells alleviates obesity-induced metabolic dysfunction.
    Palmer AK; Xu M; Zhu Y; Pirtskhalava T; Weivoda MM; Hachfeld CM; Prata LG; van Dijk TH; Verkade E; Casaclang-Verzosa G; Johnson KO; Cubro H; Doornebal EJ; Ogrodnik M; Jurk D; Jensen MD; Chini EN; Miller JD; Matveyenko A; Stout MB; Schafer MJ; White TA; Hickson LJ; Demaria M; Garovic V; Grande J; Arriaga EA; Kuipers F; von Zglinicki T; LeBrasseur NK; Campisi J; Tchkonia T; Kirkland JL
    Aging Cell; 2019 Jun; 18(3):e12950. PubMed ID: 30907060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
    Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
    J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational identification of natural senotherapeutic compounds that mimic dasatinib based on gene expression data.
    Meiners F; Hinz B; Boeckmann L; Secci R; Sueto S; Kuepfer L; Fuellen G; Barrantes I
    Sci Rep; 2024 Mar; 14(1):6286. PubMed ID: 38491064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial.
    Farr JN; Atkinson EJ; Achenbach SJ; Volkman TL; Tweed AJ; Vos SJ; Ruan M; Sfeir J; Drake MT; Saul D; Doolittle ML; Bancos I; Yu K; Tchkonia T; LeBrasseur NK; Kirkland JL; Monroe DG; Khosla S
    Nat Med; 2024 Sep; 30(9):2605-2612. PubMed ID: 38956196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fisetin is a senotherapeutic that extends health and lifespan.
    Yousefzadeh MJ; Zhu Y; McGowan SJ; Angelini L; Fuhrmann-Stroissnigg H; Xu M; Ling YY; Melos KI; Pirtskhalava T; Inman CL; McGuckian C; Wade EA; Kato JI; Grassi D; Wentworth M; Burd CE; Arriaga EA; Ladiges WL; Tchkonia T; Kirkland JL; Robbins PD; Niedernhofer LJ
    EBioMedicine; 2018 Oct; 36():18-28. PubMed ID: 30279143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Senolytic Treatment on Gene Expression in Aged Lung.
    Cho SJ; Pronko A; Yang J; Stout-Delgado H
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.